Viewing a single comment thread. View all comments

ShakeNBakeGibson OP t1_j7meg5a wrote

I love this question. We’re really lucky to already be working with two dream partners! One with Bayer in fibrosis and one with Roche/Genentech in neuroscience and a single oncology indication.

What we look for in new, transformational partnerships are threefold:

  1. Learning for us - can we learn from a partner to make the company better for the future?
  2. Impact - can we drive value for patients and our shareholders?
  3. Data - can we gain access to, retain access to, subsidize access to, or otherwise build our dataset?

[Edited - list formatting]

14